IO Biotech
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $91,443,000.
Profit Margin
| 2019 | 0 | -10.74M | |
|---|---|---|---|
| 2020 | 0 | -12.06M | |
| 2021 | 0 | -67.87M | |
| 2022 | 0 | -71.45M | |
| 2023 | 0 | -86.08M |
IOBT Income Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 756K | 540K | 0 | 0 | 0 |
Gross profit | -756K | -540K | 0 | 0 | 0 |
Operating exp. | |||||
Research and development | 67.82M | 46.98M | 30.15M | 8.46M | 7.93M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 91.44M | 71.42M | 41.23M | 10.14M | 9.91M |
Operating income | -91.44M | -71.42M | -41.23M | -10.14M | -9.91M |
Other income (expenses), net | 6.21M | 1.23M | -26.57M | -1.89M | -830K |
Income before tax | -85.23M | -70.18M | -67.81M | -12.04M | -10.74M |
Income tax expense | 852K | 1.27M | 68K | 26K | 6K |
Net income | -86.08M | -71.45M | -67.87M | -12.06M | -10.74M |
Earnings per share | |||||
Basic EPS | -1.98 | -2.48 | -2.36 | -0.42 | -0.37 |
Diluted EPS | -1.98 | -2.48 | -2.36 | -0.42 | -0.37 |
| Data source | Data source | Data source |